Thomson Resources (ASX: TMZ) could be positioned to capitalise on the precious metal resurgence, with an existing Gold portfolio and the pending acquisition of two silver assets.

The 1991 recession changed us and partly explained why we went 30 years without another one. Shouldn’t we be doing whatever it takes to restore normality?

On this week's show, Burman Invest's Julia Lee, Tribeca Investment Partners' Jun Bei Liu and Switzer's Paul Rickard join Peter Switzer.

Mernova Medicinal Inc., a wholly owned subsidiary of Creso Pharma (ASX: CPH), received three purchase orders last week with a combined value of over $288,000.

Things seem relatively positive for the Australian share market and the $A.

China’s punishing many Aussie producers but our iron prices are in a Beijing-created boom zone, which will help jobs, your super and Frydenberg’s Budget!

Here are the differences between the Pfizer and Oxford COVID-19 vaccines, and why I believe neither will be affected by the cancellation of the University of Queensland vaccine.

While Coronavirus cases are still rising in many countries, the good news is that a vaccine is out there and there’s a good chance of reaching herd immunity globally by the end of 2021 or early 2022.

Dr Ross Walker discusses the longest-running trial in relation to multivitamins and the potential benefits of long-term multivitamin use.